Pharmaniaga Bhd (7081) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.042x

Based on the latest financial reports, Pharmaniaga Bhd (7081) has a cash flow conversion efficiency ratio of -0.042x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM-20.78 Million ≈ $-5.22 Million USD) by net assets (RM489.50 Million ≈ $122.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Pharmaniaga Bhd to measure how much of total assets are equity-financed.

Pharmaniaga Bhd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Pharmaniaga Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Pharmaniaga Bhd to evaluate the quality of earnings relative to operating cash generation.

Pharmaniaga Bhd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmaniaga Bhd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
SFA Engineering Corporation
KQ:056190
0.010x
Daesang Corp
KO:001680
0.093x
Jiangxi Sunshine Dairy Co Ltd
SHE:001318
0.026x
Zhejiang Kan Specialities Material Co Ltd
SHE:002012
-0.009x
Hebei Gongda Keya Energy Technology Co. Ltd. A
SHE:301197
N/A
Prisma Properties
ST:PRISMA
-0.087x
Hollyland China Electronics Technology Corp Ltd
SHE:002729
0.036x
Jiangsu Luokai Mechanical & Electrical Co Ltd Class A
SHG:603829
0.123x

Annual Cash Flow Conversion Efficiency for Pharmaniaga Bhd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Pharmaniaga Bhd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 7081 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 RM459.15 Million
≈ $115.28 Million
RM-17.69 Million
≈ $-4.44 Million
-0.039x +86.82%
2024-12-31 RM-145.94 Million
≈ $-36.64 Million
RM42.67 Million
≈ $10.71 Million
-0.292x -70.67%
2023-12-31 RM-274.09 Million
≈ $-68.81 Million
RM46.95 Million
≈ $11.79 Million
-0.171x -141.92%
2022-12-31 RM-348.31 Million
≈ $-87.45 Million
RM-142.34 Million
≈ $-35.74 Million
0.409x +400.12%
2021-12-31 RM470.44 Million
≈ $118.11 Million
RM-64.06 Million
≈ $-16.08 Million
-0.136x -78.76%
2020-12-31 RM337.53 Million
≈ $84.74 Million
RM-25.71 Million
≈ $-6.45 Million
-0.076x -113.56%
2019-12-31 RM337.85 Million
≈ $84.82 Million
RM189.76 Million
≈ $47.64 Million
0.562x +449.59%
2018-12-31 RM509.34 Million
≈ $127.88 Million
RM-81.83 Million
≈ $-20.55 Million
-0.161x -135.44%
2017-12-31 RM528.05 Million
≈ $132.57 Million
RM239.41 Million
≈ $60.11 Million
0.453x +578.93%
2016-12-31 RM530.63 Million
≈ $133.22 Million
RM35.44 Million
≈ $8.90 Million
0.067x +434.25%
2015-12-31 RM560.00 Million
≈ $140.60 Million
RM7.00 Million
≈ $1.76 Million
0.013x -96.76%
2014-12-31 RM552.00 Million
≈ $138.59 Million
RM213.00 Million
≈ $53.48 Million
0.386x -23.89%
2013-12-31 RM503.00 Million
≈ $126.29 Million
RM255.00 Million
≈ $64.02 Million
0.507x +1355.27%
2012-12-31 RM488.00 Million
≈ $122.52 Million
RM17.00 Million
≈ $4.27 Million
0.035x --

About Pharmaniaga Bhd

KLSE:7081 Malaysia Medical Distribution
Market Cap
$421.44 Million
RM1.68 Billion MYR
Market Cap Rank
#13113 Global
#145 in Malaysia
Share Price
RM1.28
Change (1 day)
+4.07%
52-Week Range
RM0.16 - RM1.38
All Time High
RM1.38
About

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines… Read more